FDA Approves Seqirus' Fluad, First U.S. Adjuvanted Flu Vaccine
Tuesday, December 1, 2015
Source: Fierce Vaccines
The vaccine, first approved in Italy in 1997 and now licensed in 38 countries, received FDA accelerated approval for people aged 65 and older last week. With the decision, CSL's flu vaccines unit Seqirus has its first regulatory blessing since its formation in October.